The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Leshchenko I.V.

Ural'skaia gosudarstvennaia meditsinskaia akademiia Minzdrava Rossii;
Meditsinskoe ob''edinenie "Novaia bol'nitsa", Ekaterinburg

Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?

Authors:

Leshchenko I.V.

More about the authors

Journal: Therapeutic Archive. 2013;85(10): 83‑87

Read: 8874 times


To cite this article:

Leshchenko IV. Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy? Therapeutic Archive. 2013;85(10):83‑87. (In Russ.)

Recommended articles:

References:

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (Revised 2011). Dostupno na: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf
  2. Anthonisen N.R., Manfreda J., Warren C.P.W. Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
  3. Maltais F., Ostinelli J., Bourbeau J. et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2002; 165: 698-703.
  4. Gunen H., Hacievliyagil S.S., Yetkin O. et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur Respir J 2007; 29: 660-667.
  5. Fedoseev G.B., Zinakova M.K., Rovkina E.I. Klinicheskie aspekty primeneniya Askorila v pul'monologicheskoi klinike. Novye Sankt-Peterburgskie vrachebnye vedomosti 2002; 2: 64-67.
  6. Ainapure S.S., Desai A., Korde K. Efficacy and safety of Ascoril in the management of cough - National Study Group report. J Indian Med Assoc 2001; 99: 111-114.
  7. Prabhu Shankar S., Chandrashekharan S., Bolmall C.S., Baliga V. Efficacy, safety and tolerability of salbutamol+guaiphenesin+bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomized controlled comparative study. J Indian Med Assoc 2010; 108: 313-320.
  8. Jayaram S., Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients - a randomized double-blind comparative trial. J Indian Med Assoc 2000; 98: 68-70.
  9. Fedoseev G.B., Orlova N.Yu., Shalyuga L.V. Primenenie preparata "ASKORIL" v ambulatornoi praktike. Novye Sankt-Peterburgskie vrachebnye vedomosti 2002; 1: 69-70.
  10. Klyachkina L.M., Dmitriev Yu.K. Lechenie netyazhelykh obostrenii khronicheskoi obstruktivnoi bolezni legkikh. Klin med 2012; 3: 79-82.
  11. Vestbo J., Anderson W., Coxson H.O. et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE). Eur Respir J 2008; 31: 869-873.
  12. Agusti A.G., Villaverde J.M., Togores B., Bosch M. ECLIPSE cohort. Respir Res 2010; 11: 122-136.
  13. Grigor'eva N.Yu., Kuznetsov A.N., Koroleva T.V., Koroleva M.E. Kombinirovannyi preparat askoril pri lechenii khronicheskoi obstruktivnoi bolezni legkikh s soputstvuyushchei ishemicheskoi bolezn'yu serdtsa. Ter arkh 2013; 8: 104-107.
  14. Klyachkina I.L. Lechenie kashlya pri ostroi respiratornoi infektsii i grippe u patsientov gruppy riska. Farmateka 2010; 5: 125-132.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.